India to Venezuela: Rituximab Export Trade Route
India has recorded 10 verified shipments of Rituximab exported to Venezuela, representing a combined trade value of $1.1M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $108.5K USD. The leading Indian exporter is MEDWISE OVERSEAS PRIVATE LIMITED, which accounts for 100% of total export value with 5 shipments worth $1.1M USD. On the buying side, TO is the largest importer in Venezuela with $583.1K USD in purchases. The top 3 suppliers — MEDWISE OVERSEAS PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED, DHEER HEALTH CARE PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Venezuela Rituximab corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $1.1M USD. The route is dominated by MEDWISE OVERSEAS PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's rituximab manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $108.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with rituximab's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 15.9%, placing it at rank #11 among India's top rituximab export destinations globally.
On the import side, key buyers of Indian rituximab in Venezuela include TO, TO,, TO THE ORDER OF and 2 others. TO is the single largest importer with 3 shipments valued at $583.1K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#11
- Annual growth+15.9%
- Demand growth+15.7%
- Regulatory ease79/100
Top 10 Indian Rituximab Exporters to Venezuela
Showing top 10 of 3 Indian suppliers exporting Rituximab to Venezuela, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDWISE OVERSEAS PRIVATE LIMITED Avg $216.3K per shipment | 5 | $1.1M | 99.7% |
| 2 | APRAZER HEALTHCARE PRIVATE LIMITED Avg $640 per shipment | 4 | $2.6K | 0.2% |
| 3 | DHEER HEALTH CARE PRIVATE LIMITED Avg $680 per shipment | 1 | $680 | 0.1% |
This table shows the top 10 of 3 Indian companies exporting rituximab to Venezuela, ranked by total trade value. The listed exporters are: MEDWISE OVERSEAS PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED, DHEER HEALTH CARE PRIVATE LIMITED. MEDWISE OVERSEAS PRIVATE LIMITED is the dominant supplier with 5 shipments worth $1.1M USD, giving it a 100% market share.
Top 10 Rituximab Importers in Venezuela
Showing top 10 of 5 known buyers in Venezuela receiving Rituximab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian rituximab in Venezuela include TO, TO,, TO THE ORDER OF, TO THE ORDER OFF, HADDOCK PHARMA C.A.. The largest importer is TO, accounting for $583.1K USD across 3 shipments — representing 54% of all rituximab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO | 3 | $583.1K | 53.8% |
| 2 | TO, | 2 | $498.3K | 45.9% |
| 3 | TO THE ORDER OF | 2 | $2.0K | 0.2% |
| 4 | TO THE ORDER OFF | 1 | $680 | 0.1% |
| 5 | HADDOCK PHARMA C.A. | 2 | $594 | 0.1% |
Top 10 Rituximab Formulations Imported by Venezuela
Showing top 10 of 10 product formulations shipped on the India to Venezuela Rituximab route, ranked by trade value
Venezuela imports a wide range of rituximab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — RITUXIREL 500 MG (RITUXIMAB INJECTION 500 MG),(BATCH NORMV1B23033,PACK1 X 50 ML INJECTION) — accounts for $428.1K USD across 1 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RITUXIREL 500 MG (RITUXIMAB INJECTION 500 MG),(BATCH NORMV1B23033,PACK1 X 50 ML INJECTION) | 1 | $428.1K | 39.5% |
| 2 | RITUXIREL 500 MG RITUXIMAB INJECTION 500MG BN.RMV1B24001 MD.01-24 ED.12-26 | 1 | $356.2K | 32.8% |
| 3 | RITUXIREL 100 MG RITUXIMAB INJECTION 100MG BN.RMV1A23010, MD.12-23 ED11-26 | 1 | $166.9K | 15.4% |
| 4 | RITUXIREL 100 MG (RITUXIMAB INJECTION 100 MG),(BATCH NORMV1A23008,PACK1 X 10 ML INJECTION) | 1 | $70.2K | 6.5% |
| 5 | RITUXIREL 100 MG RITUXIMAB INJECTION 100MG BN.RMV1A23009, MD.12-23 ED11-26 | 1 | $60.0K | 5.5% |
| 6 | MABALL 500 MG RITUXIMAB INJ 500MG B N RB2494B MFG DT 12 24 EXP DT 11 27 | 1 | $1.5K | 0.1% |
| 7 | (HARMLESS MEDICINE) MABALL 500MG INJECTION (RITUXIMAB) (1 VIAL)NOS | 1 | $680 | 0.1% |
| 8 | MABALL 500 MG RITUXIMAB INJ 500 MG BATCH RB2418A MFG 03/2024 EXP 02/2027 | 1 | $439 | 0.0% |
| 9 | MABALL 100 MG INJ RITUXIMAB INJ 100MG B N RA2416C MFG DT 06 24 EXP DT 05 27 | 1 | $428 | 0.0% |
| 10 | MABALL 100 MG INJ RITUXIMAB INJ 100MG BATCH - RA2332A MFG - 10/2023 EXP - 09/2026 | 1 | $155 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 5 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's rituximab exports to Venezuela are driven primarily by a handful of large-scale manufacturers. MEDWISE OVERSEAS PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Venezuela benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MEDWISE OVERSEAS PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED, DHEER HEALTH CARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $108.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as rituxirel 500 mg rituximab injection 500mg bn.rmv1b24001 md.01-24 ed.12-26 and rituxirel 100 mg rituximab injection 100mg bn.rmv1a23010, md.12-23 ed11-26, suggesting that buyers in Venezuela tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO is the largest importer with 3 shipments worth $583.1K USD — representing 54% of all rituximab imports from India on this route.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $108.5K
- Suppliers
- 3
- Buyers
- 5
- Transit (Sea)
- ~15 days
- Annual Growth
- +15.9%
Other Rituximab Routes
Unlock the Full India to Venezuela Rituximab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 10 shipments on this route.
Frequently Asked Questions — India to Venezuela Rituximab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Rituximab to Venezuela?
The leading Indian exporters of Rituximab to Venezuela are MEDWISE OVERSEAS PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED, DHEER HEALTH CARE PRIVATE LIMITED. MEDWISE OVERSEAS PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Rituximab exports from India to Venezuela?
India exports Rituximab to Venezuela worth approximately $1.1M USD across 10 recorded shipments. The average value per shipment is $108.5K USD.
Q Which ports does India use to ship Rituximab to Venezuela?
The most active port of origin is DELHI AIR with 5 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from India to Venezuela for Rituximab?
The average transit time for Rituximab shipments from India to Venezuela is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Venezuela Rituximab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.9% with demand growth tracking at 15.7%. The route is ranked #11 among India's top Rituximab export destinations globally.
Q How many suppliers are active on the India to Venezuela Rituximab route?
There are currently 3 active Indian suppliers exporting Rituximab to Venezuela. The market is moderately concentrated with MEDWISE OVERSEAS PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Rituximab from India in Venezuela?
The leading importers of Indian Rituximab in Venezuela include TO, TO,, TO THE ORDER OF, TO THE ORDER OFF, HADDOCK PHARMA C.A.. TO is the largest buyer with 3 shipments worth $583.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Venezuela export trade corridor identified from Indian Customs (DGFT) records for Rituximab.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 5 importers in Venezuela matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 10 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists